Clinical outcome of children with localized osteosarcoma after chemotherapy with modified MAPIE regimen and limb salvage surgery

Changcheng CHEN,Yijin GAO,Ci PAN,Jingyan TANG

DOI: https://doi.org/10.3969/j.issn.1673-5323.2017.05.009

2017-01-01

Abstract:Objective To investigate the characteristics and treatment outcome of children with localized osteosarcoma after chemotherapy with modified MAPIE regimen and limb salvage surgery.Methods Retrospectively analyzed the children with localized osteosarcoma receiving modified MAPIE regimen between February 2013 through July 2014 at the Department of the Hematology and Oncology in Shanghai Children's Medical Center.Patients treated before 2013 constituted the historical control for evaluating the efficacy of the present regimen.Results There were 7 children who received chemotherapy with modified MAPIE,and 3 males and 4 females.The median age of the children was 11 years (ranged 3 ～15 years).The median follow-up period was 24 months (ranged 2 ～36 months).1 patient died of treatment-related complication.1 case died after lung metastasis.At the last evaluation,5 patients were in remission.6 of 7 patients in the MAPIE group underwent limb salvage procedures.The 3-year event-free survival in the MAPIE group was 71.4％ (5/7),and the 3-year EFS in the historical control group was 20.0％ (5/20).Conclusions Adjuvant chemotherapy with modified MAPIE regimen combined with limb salvage surgery achieved an improvement in outcome for children with localized osteosarcoma.Further effort will focus on serum peak methotrexate level detection in high dose MTX applixcation improve the limb salvage surgery surgeries.